|
1
|
Conic RRZ, Damiani G, Frigerio A, Tsai S,
Bragazzi NL, Chu TW, Mesinkovska NA, Koyfman SA, Joshi NP, Budd GT,
et al: Incidence and outcomes of cutaneous angiosarcoma: A SEER
population-based study. J Am Acad Dermatol. 83:809–816.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Young RJ, Brown NJ, Reed MW, Hughes D and
Woll PJ: Angiosarcoma. Lancet Oncol. 11:983–991. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Huang J and Mackillop WJ: Increased risk
of soft tissue sarcoma after radiotherapy in women with breast
carcinoma. Cancer. 92:172–180. 2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Meis-Kindblom JM and Kindblom LG:
Angiosarcoma of soft tissue: A study of 80 cases. Am J Surg Pathol.
22:683–697. 1998.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Painter CA, Jain E, Tomson BN, Dunphy M,
Stoddard RE, Thomas BS, Damon AL, Shah S, Kim D, Gómez Tejeda
Zañudo J, et al: The angiosarcoma project: Enabling genomic and
clinical discoveries in a rare cancer through patient-partnered
research. Nat Med. 26:181–187. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gaballah AH, Jensen CT, Palmquist S,
Pickhardt PJ, Duran A, Broering G and Elsayes KM: Angiosarcoma:
Clinical and imaging features from head to toe. Br J Radiol.
90(20170039)2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang L, Lao IW, Yu L and Wang J:
Clinicopathological features and prognostic factors in
angiosarcoma: A retrospective analysis of 200 patients from a
single Chinese medical institute. Oncol Lett. 14:5370–5378.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Shon W and Billings SD: Cutaneous
malignant vascular neoplasms. Clin Lab Med. 37:633–646.
2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ohsawa M, Naka N, Tomita Y, Kawamori D,
Kanno H and Aozasa K: Use of immunohistochemical procedures in
diagnosing angiosarcoma. Evaluation of 98 cases. Cancer.
75:2867–2874. 1995.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mankey CC, McHugh JB, Thomas DG and Lucas
DR: Can lymphangiosarcoma be resurrected? A clinicopathological and
immunohistochemical study of lymphatic differentiation in 49
angiosarcomas. Histopathology. 56:364–371. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Morgan MB, Swann M, Somach S, Eng W and
Smoller B: Cutaneous angiosarcoma: A case series with prognostic
correlation. J Am Acad Dermatol. 50:867–874. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fury MG, Antonescu CR, Van Zee KJ, Brennan
MF and Maki RG: A 14-year retrospective review of angiosarcoma:
Clinical characteristics, prognostic factors, and treatment
outcomes with surgery and chemotherapy. Cancer J. 11:241–247.
2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Pawlik TM, Paulino AF, McGinn CJ, Baker
LH, Cohen DS, Morris JS, Rees R and Sondak VK: Cutaneous
angiosarcoma of the scalp: A multidisciplinary approach. Cancer.
98:1716–1726. 2003.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Karnofsky DA and Burchenal JH: Evaluation
of chemotherapeutic agents. In: The Clinical Evaluation of
Chemotherapeutic Agents in Cancer. MacLeod CM, editor. Columbia
University Press, New York, pp191-205, 1949.
|
|
15
|
Takenaka R, Haga A, Nawa K, Hideomi Y and
Nakagawa K: Improvement of the robustness to set up error by a
virtual bolus in total scalp irradiation with Helical tomotherapy.
Radiol Phys Technol. 12:433–437. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hata M, Wada H, Ogino I, Omura M, Koike I,
Tayama Y, Odagiri K, Kasuya T and Inoue T: Radiation therapy for
angiosarcoma of the scalp: Treatment outcomes of total scalp
irradiation with X-rays and electrons. Strahlenther Onkol.
190:899–904. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ogawa K, Takahashi K, Asato Y, Yamamoto Y,
Taira K, Matori S, Iraha S, Yagi N, Yogi A, Haranaga S, et al:
Treatment and prognosis of angiosarcoma of the scalp and face: A
retrospective analysis of 48 patients. Br J Radiol. 85:e1127–e1133.
2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Guadagnolo BA, Zagars GK, Araujo D, Ravi
V, Shellenberger TD and Sturgis EM: Outcomes after definitive
treatment for cutaneous angiosarcoma of the face and scalp. Head
Neck. 33:661–667. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ihara H, Kaji T, Katsui K, Miyake T, Waki
T, Katayama N, Matsuzaki H, Yamasaki O, Kuroda M, Morizane S and
Kanazawa S: Single institutional experience of radiation therapy
for angiosarcoma of the scalp without cervical lymph node
metastases: Impact of concurrent chemoradiation with maintenance
chemotherapy using taxanes on patient prognosis. Mol Clin Oncol.
11:498–504. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Fujisawa Y, Yoshino K, Kadono T, Miyagawa
T, Nakamura Y and Fujimoto M: Chemoradiotherapy with taxane is
superior to conventional surgery and radiotherapy in the management
of cutaneous angiosarcoma: A multicentre, retrospective study. Br J
Dermatol. 171:1493–1500. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mark RJ, Poen JC, Tran LM, Fu YS and
Juillard GF: Angiosarcoma. A report of 67 patients and a review of
the literature. Cancer. 77:2400–2406. 1996.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Florou V, Rosenberg AE, Wieder E,
Komanduri KV, Kolonias D, Uduman M, Castle JC, Buell JS, Trent JC
and Wilky BA: Angiosarcoma patients treated with immune checkpoint
inhibitors: A case series of seven patients from a single
institution. J Immunother Cancer. 7(213)2019.PubMed/NCBI View Article : Google Scholar
|
